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Peripheral tolerance to autoantigens is induced via suppression of self-reactive lympho-
cytes, stimulation of tolerogenic dendritic cells (DCs) and regulatory T (Treg) cells. 
Interleukin (IL)-27 induces tolerogenic DCs and Treg cells; however, it is not known 
whether IL-27 is important for tolerance induction. We immunized wild-type (WT) and 
IL-27 receptor (WSX-1) knockout mice with MOG35–55 for induction of experimental 
autoimmune encephalomyelitis and intravenously (i.v.) injected them with MOG35–55 after 
onset of disease to induce i.v. tolerance. i.v. administration of MOG35–55 reduced disease 
severity in WT mice, but was ineffective in Wsx−/− mice. IL-27 signaling in DCs was 
important for tolerance induction, whereas its signaling in T cells was not. Further mech-
anistic studies showed that IL-27-dependent tolerance relied on cooperation of distinct 
subsets of spleen DCs with the ability to induce T cell-derived IL-10 and IFN-γ. Overall, 
our data show that IL-27 is a key cytokine in antigen-induced peripheral tolerance and 
may provide basis for improvement of antigen-specific tolerance approaches in multiple 
sclerosis and other autoimmune diseases.
Keywords: interleukin 27, tolerance, experimental autoimmune encephalomyelitis, dendritic cells, immunomodulation
inTrODUcTiOn
Given that autoimmune diseases result from an imbalance between tolerance and immune response 
against self-antigens (Ag), induction of Ag-specific immune tolerance is a desired goal in therapy. 
Peripheral tolerance to innocuous Ags can be achieved by their intravenous (i.v.) administration 
or via mucosal surfaces in non-immunizing conditions. Oral delivery of auto-Ags reduces the 
severity of autoimmunity in disease models such as collagen-induced arthritis and experimental 
autoimmune encephalomyelitis (EAE), the prototypical model for human multiple sclerosis (MS) 
(1–5). i.v. delivery of auto-Ag reduces severity of EAE by stimulating tolerogenic dendritic cells 
(DCs) and regulatory T (Treg) cells leading to modulation of Ag-presentation (6, 7). Th17, Th1, 
and memory T cells are suppressed in i.v.-tolerized EAE mice through the modulation of JAK/
STAT pathways (8–10). In summary, both oral and i.v. tolerance elicit Ag-specific immunomodula-
tion that relies on stimulation of tolerogenic DCs, Tregs, and augmentation of anti-inflammatory 
cytokine production (11).
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Interleukin (IL)-27 is an anti-inflammatory cytokine that 
stimulates development of IL-10-producing type 1 regulatory T 
(Tr1) cells in a STAT-1-dependent pathway (12, 13). Exposure 
to IL-27 also suppresses Th17 differentiation while stimulating 
expression of the coinhibitory molecule Tim-3 by T cells (14–16). 
IFN-γ-primed DCs secrete IL-27 and induce IL-10 production 
by T  cells to reduce EAE (17). WSX-1 (IL-27Rα) and gp130 
are subunits of the heterodimeric receptor for IL-27. WSX-1 is 
expressed in T cells, macrophages, B cells, and DCs (13, 18–20). 
In DCs, IL-27 signaling induces expression of CD39 and B7-H1, 
which play a suppressive role in EAE development (21, 22). 
These observations place IL-27 among key immunomodulatory 
cytokines; however, the role of IL-27 in peripheral tolerance is 
not known.
In this study, we investigated the role of IL-27 in peripheral 
tolerance. Wsx−/− mice with EAE were resistant to tolerance 
induction by i.v. or oral delivery of Ag, and lack of WSX-1 only 
in T  cells did not abrogate tolerance induction. Conversely, 
transfer of wild-type (WT) DCs to Wsx−/− mice rendered them 
susceptible to i.v. tolerance induction. Transfer of IL-10−/− DCs 
to Wsx−/− mice abrogated i.v. tolerance induction, showing that 
peripheral tolerance is dependent, at least in part, on IL-27-
induced IL-10 production by DCs. Furthermore, by using 
isolated specific subsets of splenic DCs, our data suggest the 
existence of a cooperation among spleen DC subpopulations 
that leads to increased IFN-γ, IL-10, and L-27 production and 
suppression of IL-17. Altogether, these observations highlight 
the pivotal role of IL-27 in induction of peripheral tolerance 
in autoimmune inflammation and provide a basis for future 
therapeutic approaches aiming to induce tolerance in patients 
with MS and other autoimmune diseases.
MaTerials anD MeThODs
Mice
Age- and sex-matched WT, RAG-1−/−, Wsx−/−, IL-10−/−, and 
STAT1−/− female mice on the C57BL/6 background were pur-
chased from The Jackson Laboratory (Bar Harbor, ME, USA). 
Mice were kept in clean cages with a maximum of 5 mice per cage, 
in a controlled environment with 12/12 h of light/dark cycles and 
food ad libitum throughout the experimental procedures. Every 
effort was made to minimize suffering of mice. Experimental 
protocols were approved by the Institutional Animal Care and 
Use Committee of Thomas Jefferson University.
eae induction and evaluation
Experimental autoimmune encephalomyelitis was induced as 
previously described (23). Anesthetized mice were subcutane-
ously injected with 200 µL of an emulsion containing 200 µg of 
MOG35–55 peptide (MEVGWYRSPFSRVVHLYRNGK, Genscript, 
NJ, USA) and equal volume of Complete Freund’s adjuvant 
supplemented with 10  mg/mL of heat-killed Mycobacterium 
tuberculosis H37Ra. Additionally, mice were intraperitoneally 
injected with 240 ng of pertussis toxin at immunization time and 
48 h later. Disease development was analyzed daily and scored on 
a 0–5 scale: 0—no clinical signs, 1—limp tail, 2—hind limb weak-
ness, 3—hind limb paralysis, 4—hind limb paralysis and front 
limb weakness, and 5—full paralysis/death. Cumulative scores 
were calculated as the sum of all daily scores of each individual 
mouse divided by the number of mice in each group.
i.v. and Oral administration of auto-ag
Intravenously tolerance was induced as previously described (6). 
Briefly, each mouse received 200 µg of MOG35–55 peptide in 100 µL 
of PBS at days 14, 17, and 21 postimmunization (p.i.). Control 
mice received PBS only. Induction of oral tolerance followed a 
previously described protocol (2), where each mouse was given 
200 µg of MOG35–55 peptide by oral gavage at days 14, 16, and 18 
p.i. and control mice received PBS.
ag-specific recall response
Experimental autoimmune encephalomyelitis mice were dis-
sected at day 21 p.i. and draining lymph nodes and spleens were 
collected in Iscove’s modified Dulbecco’s medium (IMDM), 
supplemented with 10% heat-inactivated fetal bovine serum, 
penicillin (100  U), streptomycin (10  µg/mL), l-glutamine 
(0.3  mg/mL), and 2-mercaptoethanol (55  µM) (referred to as 
complete IMDM) and disrupted through a 70 µm cell strainer 
to prepare single cell suspensions. After treatment with RBC 
lysis buffer (Biolegend, CA, USA) cells were extensively washed 
with complete IMDM by centrifugation at 1,300 rpm for 5 min 
at 4°C and the cell density was adjusted to 2 million cells/mL. 
100 µL of adjusted cell suspension was added to each well of a 
96 well plate. The same volume of MOG35–55 (100 µg/mL) was 
added to wells to a final concentration of 50 µg/mL of antigen. 
Cells were incubated at 37°C for 72 h. For negative control, cells 
were cultured without Ag, while cells treated with anti-CD3 and 
anti-CD28 (1  µg/mL each) served as a positive control. After 
the incubation period, supernatants were collected and stored 
at −20°C until use and cells were analyzed for proliferation by 
flow cytometry.
cytokine Detection in culture 
supernatants
Supernatants from cell cultures were kept at −20°C until use. 
Cytokine concentrations in culture supernatants were measured 
with sandwich enzyme-linked immunosorbent assay (ELISA) 
using commercial kits, following the manufacturer’s recom-
mendation (R&D Systems, Minneapolis, MN, USA). The fol-
lowing cytokines were measured: IFN-γ, IL-17, IL-10, IL-27, and 
GM-CSF.
isolation of cns cells and Flow cytometry
Mononuclear cells from the CNS of EAE mice were isolated by 
Percoll gradient centrifugation. In brief, mice were euthanized 
and perfused with ice-cold PBS. Brains and spinal cords were 
removed and placed in IMDM, mechanically dissociated with 
scissors and enzymatically digested by incubation with 700 µg/mL 
Liberase TL (Sigma-Aldrich, USA) at 37°C for 30  min. The 
preparation was then washed in IMDM, and the pellet was 
fractionated on a 70/30% Percoll gradient. MNCs were recovered 
from the interface, washed, and resuspended in IMDM/10% FBS. 
One million cells were transferred to FACS tubes. CNS cells were 
stimulated with PMA (50  ng/mL) and ionomycin (500  ng/mL) 
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in the presence of GolgiPlug (1  μg/106 cells) for 4  h at 37°C. 
Cells were washed in FACS buffer (PBS/2% FBS) and stained 
with fluorochrome-labeled Abs to CD45 (Clone 30-F11), CD4 
(Clone GK1.5), CD11c (Clone N418), CD11b (Clone M1/70), 
CD103 (Clone 2E7), MHC-II (Clone M5/114.15.2), CD86 (Clone 
PO3), and IL-27Rα (Clone 2918, BD Biosciences) for 20 min at 
4°C in a final volume of 100 µL. Cells were washed, fixed, and 
permeabilized using Fix and Perm cell permeabilization rea-
gents (eBioscience). Cells were intracellularly stained for IL-10 
(Clone JES5-16E3), IL-17 (Clone TC11-18H10.1), IL-27 (Clone 
MM27-7B1), GM-CSF (Clone MP1-22E9, BD Biosciences), IFN-γ  
(XMG 1.2), or Foxp3 (Clone FJK-16s, eBioscience) for 30 min 
at 4°C in a final volume of 100 µL. Unless otherwise stated, all 
antibodies were from Biolegend, CA. Data were acquired on a 
FACSAria (BD Bioscience) and analyzed using FlowJo Software 
(Tristar Inc.).
reconstitution of Wsx−/− Mice  
and eae induction
Wsx−/− mice received magnetic bead-isolated CD11c+ DCs from 
spleens of WT, IL-10−/−, and Wsx−/− mice. Each mouse received 
1 million CD11c+ DCs by i.v. injection under anesthesia. After 
72 h of adoptive transfer, anesthetized reconstituted Wsx−/− mice 
were immunized with MOG35–55 peptide in CFA to induce EAE, 
as described above. Disease development was evaluated daily.
reconstitution of rag1−/− Mice  
and eae induction
RAG1−/− mice were reconstituted with magnetic bead-isolated 
total CD4+ T cells from spleens of WT and Wsx−/− mice. Each 
mouse received 2 million CD4+ T  cells via i.v. injection under 
anesthesia. After 72 h of adoptive transfer, EAE was induced in 
reconstituted mice as described above.
OVa immunization and Treatment
Anesthetized female WT C57BL/6 mice were subcutaneously 
injected with 100 µL of an emulsion containing 100 µg of OVA 
(grade V, Sigma-Aldrich, St. Louis, MO, USA) and an equal 
volume of CFA supplemented with 4  mg/mL of Heat-Killed 
Mycobacterium tuberculosis H37Ra. Seven days later, mice 
were i.v. given 100 µL of OVA-Alexa Fluor 647 (Thermo Fisher 
Scientific, MA, USA). Mice were dissected after 2 h of OVA injec-
tion, and spleens, draining, and mesenteric lymph nodes were 
collected, stained, and analyzed by flow cytometry.
Dc sorting and culture
Splenic CD11c+ DCs were isolated from spleens from MOG35–55-
tolerized and non-tolerized EAE mice using magnetic beads 
(CD11c+ cell isolation kit, Miltenyi Biotec, CA, USA). Isolated 
DCs were surface stained with antibodies against CD11c, CD11b, 
and CD103 for 20 min at 4°C and then sorted into four CD11c+ 
populations: CD11b−CD103−, CD11b+CD103−, CD11b+CD103+, 
and CD11bhiCD103+. Sorting was performed on FACSAria III 
(BD Biosciences, CA, USA). Sorted DCs were plated in U-bottom 
96 well plates at a density of 20,000 cells/well. For Ag-presentation 
assays, naive CD4+ T  cells from WT mice were isolated using 
magnetic beads (Naive CD4+ T cell isolation kit, Miltenyi Biotec, 
CA, USA). Isolated T  cells were CD3+CD4+CD44−CD62L+ as 
analyzed by flow cytometry. 200,000 naive CD4+ T  cells were 
added to each well of the cell culture plate containing DCs (ratio 
of 1 DC: 10 T  cells) and plates were incubated at 37°C in the 
presence of anti-CD3 (0.5 µg/mL). Cells were collected after 72 h 
and analyzed by flow cytometry, while cytokine concentrations in 
culture supernatants were measured by ELISA.
generation of Bone Marrow-Derived Dcs
Dendritic cells were generated from bone marrow precursors, 
according to a previously described protocol (24, 25). Briefly, 
precursors from WT mice were seeded at 1 million cells/mL 
in Petri dish in complete IMDM supplemented with 10 ng/mL 
of GM-CSF. Culture medium was changed on days 3 and 6. At 
day 7, cells were collected, washed in fresh complete media and 
transferred to appropriate culture plates for specific treatments. 
Maturation of the DCs was induced with lipopolysaccharide 
(100 ng/mL) and cells were cultured in the presence/absence of 
IL-27 (20 ng/mL) for 18 h and used in Ag-presentation assays or 
adoptive transfer experiments.
statistical analysis
Daily clinical scores among experimental groups in EAE were 
compared by two-way ANOVA and posttested with Sidak. 
Analyses between three or more groups were performed with 
one-way ANOVA and posttested with Bonferroni. Comparisons 
between two groups were carried out with Student’s t-test. Values 
of p < 0.05 were considered significant.
resUlTs
il-27 is necessary for Tolerance  
induction in eae
We first tested whether IL-27 is necessary for induction of toler-
ance in EAE. Wsx−/− and WT C57BL/6 mice were immunized 
with MOG35–55 peptide to induce EAE. At day 14 p.i., when 
clinical disease had already developed, mice received i.v. 200 µg 
of MOG35–55 and treatment continued with two additional doses 
of MOG35–55 3  days apart. While, compared with PBS-treated 
controls, MOG35–55 treatment significantly reduced clinical score 
in WT mice, it had little effect in Wsx−/− mice (Figures 1A,B). 
MOG35–55-treated mice had fewer leukocytes in the CNS com-
pared to PBS-treated WT mice and MOG35–55- and PBS-treated 
Wsx−/− mice (Figure 1C). i.v. injection of MOG35–55 increased the 
frequencies of IL-10+ CD4+ T cells while inhibiting IL-17- and 
GM-CSF-producing T cells in the CNS of WT, but not of Wsx−/− 
mice (Figure 1D). No significant differences were observed in total 
frequency of Foxp3+CD4+ T cells (Figure 1D). However, due to 
lower numbers of infiltrating cells in the CNS of WT mice treated 
with MOG35–55, absolute numbers of IL-10+, Foxp3+, IFN-γ+, 
IL-17+, and GM-CSF+ CD4+ T cells were reduced in these mice 
compared to other groups (Figure  1D). In addition, cytokine 
production from Ag-specific ex vivo re-stimulated spleen cells 
from WT MOG-treated mice revealed a shift toward IL-10 and 
IL-27 production and suppression of IL-17, GM-CSF and IFN-γ 
production compared to cells from PBS-treated mice, whereas 
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FigUre 1 | Continued
FigUre 1 | Continued  
Lack of interleukin (IL)-27Rα precludes the therapeutic effect of intravenous (i.v.) MOG35–55. Wild-type (WT) and Wsx−/− mice (n = 5 per group) were immunized with 
MOG35–55 to induce experimental autoimmune encephalomyelitis (EAE). At days 14, 17, and 20 postimmunization (p.i.), mice were i.v. injected with 200 µg of 
MOG35–55 to induce tolerance. (a) Daily clinical scores of disease severity. (B) Cumulative scores of disease severity. (c) Mice were dissected at day 21 p.i. and 
CD45+ CNS-infiltrating cells numbers were determined by flow cytometry and hemocytometer. (D) Flow cytometry analysis of IL-10+, Foxp3+, IL-17+, GM-CSF+, and 
IFN-γ+ CD4+ T cells from the CNS of EAE mice described above. (e) Cytokine concentrations in supernatants from cultures of spleen cells from EAE mice were 
determined by ELISA. Results are representative of three independent experiments with similar outcomes. Bar graphs depict mean ± standard error mean (SEM). 
Values of p < 0.05 (*), p < 0.01 (**) were considered statistically significant. Two-way ANOVA [in (a)] and one-way ANOVA (B,c,e) with Bonferroni posttest were 
used to analyze data.
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such a pattern was not observed in cultures from Wsx−/− mice 
(Figure 1E). In summary, i.v. tolerance in EAE is followed by a 
modulation of the immune response in the CNS and secondary 
lymphoid organs in an IL-27-dependent manner.
In order to investigate whether IL-27 is also necessary for 
oral tolerance induction, WT and Wsx−/− EAE mice were fed 
with three 200 µg doses of MOG35–55 every other day starting at 
disease onset. Similar to the i.v. tolerance model, WT mice fed 
with MOG35–55 developed significantly less severe EAE compared 
to PBS-fed mice, but this effect was not observed in Wsx−/− mice 
(Figure S1A in Supplementary Material). Significantly fewer 
cells infiltrated the CNS of MOG35–55-fed WT mice compared 
with controls, whereas there was no difference between test and 
control groups of Wsx−/− mice (Figure S1A in Supplementary 
Material). MOG-fed WT mice also had similar frequencies of 
IL-10-producing Foxp3+ Treg cells and IFN-γ-, IL-17-, and 
GM-CSF-producing CD4+ T  cells compared to Wsx−/− mice 
and PBS-fed controls (Figure S1B in Supplementary Material). 
DC maturation was suppressed in MOG-fed WT mice, but not 
in other groups (Figure S1C in Supplementary Material). As 
previously described by our group (6), DCs from i.v. tolerized 
mice also show reduced expression of Ag-presenting molecules 
(data not shown). Interestingly, oral tolerance seems less effec-
tive than i.v. tolerance in suppressing EAE. We speculate that 
MOG peptide is readily available to APCs and T cells following 
i.v. administration, whereas gastric acid and oral mucosa barrier 
may interfere with the bioavailability of orally delivered peptides. 
We believe that oral and i.v. administration of peptides leads to 
tolerance through different pathways that converge in IL-27R 
signaling as both approaches (i.v. and oral tolerance) failed to 
suppress disease in Wsx−/− mice. Taken together, these observa-
tions indicate that IL-27 is a key cytokine for inducing peripheral 
tolerance via i.v. and oral route.
il-27 signaling in T cells is Dispensable 
for induction of Peripheral Tolerance
To determine whether IL-27 signaling in T cells plays a role in 
tolerance induction, we reconstituted RAG1−/− mice with WT or 
Wsx−/− CD4+ T cells and immunized them for EAE induction. 
Mice were i.v. injected with 200 µg of MOG35–55 on days 14, 17, and 
20 p.i. Both RAG1−/− mice reconstituted with WT and with Wsx−/− 
CD4+ T  cells and i.v. tolerized developed significantly milder 
disease than their PBS-treated counterparts (Figures 2A,B). i.v. 
administration of MOG35–55 significantly reduced numbers of 
infiltrating cells in the CNS of mice that were reconstituted with 
WT and Wsx−/− CD4+ T cells (Figure 2C). Among infiltrating 
cells, we observed a reduction in frequency of IL-17+ T cells irre-
spective of WSX expression in T cells (Figure 2D). Frequencies 
of IL-10+ and IFN-γ+ T cells were increased only in i.v. tolerized 
RAG1−/− mice reconstituted with WT CD4+ T cells (Figure 2C). 
However, due to lower numbers of infiltrating cells in the CNS 
of mouse treated with MOG35–55, absolute numbers of IFN-γ+, 
IL-17+, and GM-CSF+ CD4+ T cells were reduced in these mice 
compared to PBS-treated groups (Figure  1D). Interestingly, 
IL-10+ and Foxp3+ CD4+ T  cell numbers were comparable 
between PBS and MOG-treated groups (Figure 2D). Tolerized 
mice also had a higher frequency of spleen Foxp3+ Treg cells 
compared to PBS-treated mice, irrespective of WSX expression 
(data not shown). These results suggest that IL-27 signaling in 
T cells is not necessary for immune modulation after i.v. delivery 
of auto-Ag.
il-27rα expression by Dcs is required 
for Peripheral Tolerance induction via a 
Mechanism That is Dependent on il-10 
Production by Dcs
Given that DCs also express WSX, we then analyzed the fre-
quency and phenotype of DCs in the CNS of RAG-1−/− mice 
reconstituted with WT and Wsx−/− CD4+ T  cells. i.v. tolerized 
mice had a higher frequency of DCs in the CNS and these cells 
expressed less MHC class II and CD80 (Figure 3A). DCs from 
i.v. tolerized mice also produced higher levels of IL-10 compared 
to PBS-treated mice (Figure 3B). Of note, DCs from i.v. tolerized 
mice that received Wsx−/− T cells had fewer IL-10+ DCs compared 
to i.v. tolerized mice that were reconstituted with WT T  cells 
(Figure  3B). These observations indicate that IL-27 signaling 
in non-CD4+ T cells, such as DCs, is required for induction of 
Ag-specific tolerance in ongoing inflammation.
We then investigated the role of IL-27 signaling in DCs in 
i.v. tolerance induction. CNS-infiltrating DCs obtained from i.v. 
MOG35–55-treated WT mice with EAE had higher IL-10 produc-
tion compared to PBS-treated controls (Figure 3C). No signifi-
cant change in IL-27 production was observed between DCs from 
PBS and MOG35–55-treated groups (Figure 3C). DCs from CNS of 
i.v. tolerized mice also showed lower expression levels of MHC-II, 
CD80, and CD86 molecules compared to PBS-treated counter-
parts (data not shown). Interestingly, DCs in the CNS expressed 
significantly higher levels of IL-27Rα compared to T cells, and its 
expression was increased in i.v. tolerized mice (Figure 3D). These 
observations suggested that DCs may be relevant to the role of 
IL-27 in tolerance induction.
FigUre 2 | Absence of interleukin (IL)-27Rα in T cells does not preclude i.v. tolerance induction. RAG1−/− mice were reconstituted with total CD4+ T cells from 
wild-type (WT) or Wsx−/− mice. 72 h postreconstitution, recipient mice were immunized for EAE induction and MOG35–55 (200 μg/dose) was given i.v. at days 14, 17, 
and 20 postimmunization (p.i.). (a) Daily clinical scores of disease severity. (B) Cumulative scores of disease severity. (c) Mice were dissected on day 21 p.i. and 
CD45+ CNS-infiltrating cells numbers were determined by flow cytometry and hemocytometer. (D) Flow cytometry analysis of IL-10+, Foxp3+, IL-17+, GM-CSF+, and 
IFN-γ+ CD4+ T cells from the CNS of EAE mice described above. Bar graphs depict mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) were considered statistically 
significant. Two-way ANOVA [in (a)] and one-way ANOVA [in (B)] with Bonferroni posttest were used for data analyses. Data are representative of two independent 
experiments with n ≥ 3 mice per group with similar outcomes.
6
Thomé et al. The Role of IL-27 in Peripheral Tolerance
Frontiers in Immunology | www.frontiersin.org October 2017 | Volume 8 | Article 1392
FigUre 3 | Changes in dendritic cells (DCs) frequency and phenotype in i.v. tolerized mice. (a) RAG1−/− reconstituted with total CD4+ T cells from wild-type (WT) 
or Wsx−/− mice were immunized to induce experimental autoimmune encephalomyelitis (EAE). At day 21, postimmunization (p.i.) mice were dissected and 
analyzed for frequency and phenotype of DCs. Flow cytometry analysis of frequency of DCs (CD11c+MHC II+) and expression of MHC class II and CD80 
expression on DCs from the CNS and spleens of mice. (B) IL-10 production by DCs from the CNS of EAE mice. (c) Frequency and absolute numbers of DCs in 
CNS and spleens of WT EAE mice and detection of IL-10 and IL-27 production by DCs. (D) IL-27Rα expression in T cells and DCs from the CNS of WT EAE mice 
at day 21 p.i. Representative data from three independent experiments. Bar graphs depict mean ± SEM. Values of p < 0.05 (*) were considered statistically 
significant. NS, not significant.
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To test this possibility, we reconstituted Wsx−/− mice with 
splenic CD11c+ DCs from WT mice, and as controls we transferred 
Wsx−/− DCs to Wsx−/− mice. In this system, a fraction among DCs 
in Wsx−/− mice could respond to IL-27 as they express IL-27Rα. 
Reconstituted mice were then immunized for EAE induction and 
subsequently subjected to i.v. tolerance induction. Wsx−/− mice 
reconstituted with WT DCs developed significantly less severe 
EAE after i.v. MOG35–55 treatment, whereas disease in Wsx−/− mice 
that received Wsx−/− DCs was not influenced by i.v. tolerization 
(Figures 4A,B). Analysis of CNS-infiltrating T cells from mice 
that received WT DCs showed that disease amelioration corre-
lated with a reduced infiltration of cells in the CNS (Figure 4C). 
Mice recipient of WT DCs showed an increase in the frequen-
cies of IFN-γ- and IL-10-producing T  cells and a reduction in 
frequency of IL-17- and GM-CSF-producing T cells (Figure 4D). 
On the other hand, mice that had received Wsx−/− DCs had only 
minor changes in the frequencies of cytokine-producing T cells 
in the CNS, although a significant reduction of IL-17+ T cells was 
observed (Figure 4D). Due to a lower infiltration of cells in the 
CNS of i.v. tolerized mice recipient of WT DCs, absolute numbers 
of IL-10+ and IFN-γ+ CD4+ T cells did not show significant differ-
ences compared to their PBS-treated counterparts (Figure 4D). 
Still, absolute numbers of IL-17+ and GM-CSF+ CD4+ T cells were 
reduced in i.v. tolerized mice recipient of WT DCs compared to 
PBS-treated counterparts (Figure 4D). In summary, these data 
show that tolerance induction in ongoing inflammation requires 
IL-27 signaling in DCs, leading to disease suppression by aug-
menting IFN-γ and IL-10 production and dampening Th17 and 
GM-CSF+ CD4+ T cells.
Given that STAT1 is the principal signaling molecule down-
stream of IL-27R in T cells, we tested whether STAT1 is also involved 
in IL-27-mediated DC modulation. Immature and mature bone 
marrow-derived DCs were treated with IL-27 for 18 h and their 
expression of surface markers involved with Ag-presentation was 
evaluated. Consistent with data from the literature (21), IL-27-
treated mature WT DCs had reduced expression of MHC class II, 
CD80, and CD86 (Figure S2A in Supplementary Material). When 
cultured with naive T  cells, IL-27-treated WT DCs suppressed 
GM-CSF production while inducing IL-10 by T  cells (Figures 
S2B,C in Supplementary Material, respectively). IL-27-treated 
STAT1− (S1−) DCs had a similar pattern of surface molecule 
expression as WT DCs (Figure S2A in Supplementary Material) 
and also suppressed GM-CSF production and induced IL-10 in 
T cells (Figures S2B,C in Supplementary Material, respectively). 
WT and S1− IL-27-treated DCs stimulated IFN-γ production 
by T cells (Figures S2B,C in Supplementary Material), which is 
consistent with our findings of more IFN-γ-producing T  cells 
in the CNS of i.v. tolerized WT DC-reconstituted Wsx−/− mice 
(Figure 4D). We did not detect IL-17 in this culture system (data 
not shown). Upon adoptive transfer into EAE mice, IL-27-treated 
WT and S1− DCs ameliorated clinical disease and reduced cellular 
infiltration in the CNS (Figure S2D in Supplementary Material). 
Analysis of CD45+CD3+CD4+ T cells that infiltrated the CNS of 
mice transferred with IL-27-treated WT and S1- DCs showed 
higher frequency of Foxp3+ and IL-10+ CD4+ T cells (Figure S2E in 
Supplementary Material). We observed a reduction in frequency 
of IFN-γ+, IL-17+, and GM-CSF+ CD4+ T cells only in recipients 
of IL-27-treated WT DCs, but not in recipients of S1− DCs (Figure 
FigUre 4 | Interleukin (IL)-27 signaling in dendritic cells (DCs) is required for intravenous (i.v.) tolerance induction in ongoing experimental autoimmune 
encephalomyelitis (EAE). Wsx−/− mice were reconstituted with wild-type (WT) and Wsx−/− CD11c+ DCs and 72 h later were immunized to induce EAE. EAE mice 
received i.v. MOG at days 14, 17, and 20 postimmunization (p.i.) to induce tolerance. Clinical (a) and cumulative (B) scores are shown. (c) Mice were dissected on 
day 21 p.i. and CD45+ CNS-infiltrating cells numbers were determined by flow cytometry and hemocytometer. (D) Flow cytometry analysis of IL-10+, Foxp3+, IL-17+, 
GM-CSF+, and IFN-γ+ CD4+ T cells from the CNS of EAE mice described above. Bar graphs depict mean ± SEM. Data are from three independent experiments with 
n of 5 mice per group with similar outcomes. *p < 0.05 [Student’s t-test in (a); two-way ANOVA in (B), one-way ANOVA in (c)]. ns, not significant.
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FigUre 5 | Interleukin (IL)-27-induced dendritic cell (DC)-derived IL-10 is necessary for peripheral tolerance induction. Wsx−/− mice were reconstituted with 
wild-type (WT), Wsx−/− or IL-10−/− CD11c+, DCs and 72 h later immunized to induce experimental autoimmune encephalomyelitis (EAE). EAE mice received 
intravenous (i.v.) MOG at days 14, 17, and 20 p.i. to induce tolerance. Clinical (a) and cumulative (B) scores are shown. (c) Mice were dissected on day 21 p.i. and 
CD45+ CNS-infiltrating cells numbers were determined by flow cytometry and hemocytometer. (D) Frequency and absolute numbers of CNS-infiltrating GM-CSF+, 
IL-17+, IFN-γ+, IL-10+, and Foxp3+ CD4+ T cells. Bar graphs depict mean ± SEM. Data are from three independent experiments with n of 5 mice per group with 
similar outcomes. *p < 0.05 [Student’s t-test in (a); two-way ANOVA in (B), one-way ANOVA in (c)]. ns, not significant.
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S2E in Supplementary Material). Absolute numbers of CNS infil-
trating IFN-γ+, IL-17+, and GM-CSF+ CD4+ T cells were reduced 
in mice recipient of IL-27-treated WT and S1− DCs (Figure S2E in 
Supplementary Material). These data show that STAT1 signaling 
is not necessary for IL-27-induced DC modulation.
Next, we tested whether IL-10 production by DCs plays a role 
in induction of peripheral tolerance. To that end, we reconstituted 
Wsx−/− mice with WT, Wsx−/−, or IL-10−/− CD11c+ DCs and 
subjected EAE mice to i.v. tolerance induction. Lack of IL-10 
production by DCs reduced the protective effect of i.v. MOG35–55 
administration (Figures 5A,B). Analysis of CNS-infiltrating cells 
showed that only mice recipient of WT DCs had a reduction in 
total cell numbers (Figure  5C). Analysis of CD45+CD3+CD4+ 
T  cells that infiltrated the CNS of mice recipient of IL-10−/− 
DCs showed a reduction infrequency and numbers of IL-17+ 
T cells compared to PBS-treated counterparts (Figure 5D). No 
significant differences were observed in frequency and numbers of 
Foxp3+, IL-10+, IFN-γ+, and GM-CSF+ CD4+ T cells in the CNS 
of mice recipient of IL-10−/− DCs compared to their PBS-treated 
counterparts (Figure  5D). Taken together, these observations 
show that induction of peripheral tolerance in ongoing inflam-
mation relies on IL-27 signaling, which through IL-10-dependent 
and STAT1-independent mechanisms, modifies DCs to promote 
IFN-γ and IL-10 production by T cells in the CNS of EAE mice.
specific subsets of splenic Dcs from  
i.v. Tolerized Mice stimulate iFn-γ, il-10, 
and il-27 Production in an il-27-
Dependent Manner
Given that DCs comprise multiple cell types with distinct func-
tions in immunity, infection and tolerance (26–31), we tested 
FigUre 6 | Specific subsets of splenic dendritic cells (DCs) from intravenously (i.v.) tolerized mice induce IFN-γ, interleukin (IL)-10, and IL-27 production in an 
IL-27-dependent manner. (a) Flow cytometry analysis of CD11c+ DCs subpopulations isolated from spleens of naive mice. (B) OVA-AF647 uptake by DC subsets in 
spleen, mesenteric lymph node, and draining lymph node 2-h post i.v. injection. (c) FACS-sorted DCs were cultivated with wild-type (WT) T cells and anti-CD3 
(0.5 µg/mL) at 37°C. After 72 h, cells were analyzed by flow cytometry for expression of cytokines. (D) Supernatants were assayed by ELISA. Bar graphs depict 
mean ± SEM. Data are representative from three independent experiments with n ≥ 5 mice per group with similar outcomes. *p < 0.05 (Student’s t-test). Bars 
depict Mean ± SEM.
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whether a particular DC type has a prominent role in capturing 
auto-Ag and stimulating T cell response. Based on CD11b and 
CD103 expression in isolated CD11c+ DCs, we distinguished 
four DC populations (CD11b−CD103−, CD11b+CD103−, 
CD11b+CD103+, and CD11bhiCD103+) from the spleen of 
WT mice (Figure 6A). To determine whether a particular DC 
subpopulation captures Ag in the course of inflammation, we 
subcutaneously immunized WT mice with OVA/CFA and i.v. 
injected Alexa Fluor 647-conjugated OVA (OVA-AF647) 7 days 
later. Two hours after OVA-AF647 injection, spleens, drain-
ing, and mesenteric lymph nodes were collected and assessed 
for AF647 fluorescence in each DC subset by flow cytometry. 
OVA-AF647 was primarily captured by CD11bhiCD103+ and 
CD11b+CD103+ DCs in spleens and, to a lesser extent, in dLN 
and mLN (Figure  6B), suggesting that splenic CD103+ DCs 
predominantly capture i.v. delivered Ags.
We then investigated whether CD103+ DCs from tolerized 
EAE mice are responsible for T  cell modulation. WT and 
11
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Wsx−/− EAE mice were i.v. tolerized and DC subsets from spleens 
sorted and cultured with naive CD4+ T cells (1 DC: 10 T ratio) 
for 72 h. CD11b−CD103− cells did not express CD80, CD86 and 
MHC-II and were unable to stimulate T cells in vitro (data not 
shown); therefore, this subpopulation was excluded from further 
analysis. CD11b+CD103+ DCs from i.v. tolerized WT mice were 
potent inducers of IFN-γ and IL-10 production compared to 
other DC subpopulations (Figures 6C,D). CD11b+CD103− and 
CD11bhiCD103+ DCs from WT i.v. tolerized mice suppressed 
IL-17 production by T cells completely measured by ELISA, even 
though flow cytometry analysis did not show such suppression 
pattern (Figures 6C,D). Corresponding Wsx−/− DCs increased 
IL-17 production (Figures 6C,D). Expression of the activation 
marker CD69 in cultured T cells was significantly lower when 
cells were cultured with CD11b+CD103− and CD11b+CD103+ 
DCs from i.v. tolerized WT mice compared to their PBS-treated 
counterparts and Wsx−/− DCs (Figure  6C). IL-27 production 
was upregulated in co-cultures with CD11b+CD103− DCs from 
MOG-treated WT mice compared to other DC subtypes and 
DCs from Wsx−/− mice (Figure 6D). Interestingly, Wsx−/− DCs 
failed to stimulate production of IFN-γ and IL-10 but efficiently 
produced IL-27 (Figure 6D). Taken together, our data show that 
IL-27 induces IL-10 production by DCs to establish peripheral 
tolerance in ongoing inflammation and that distinct subpopula-
tions of splenic DCs cooperate in this phenomenon.
DiscUssiOn
Ag-specific tolerance is a common goal in transplantation and 
autoimmune therapies. Peripheral tolerance induced against self 
and foreign Ags may be achieved by delivering them through 
“tolerogenic routes” such as nasal, oral, and i.v. (1, 6). Peripheral 
tolerance is associated with a reduced inflammatory profile 
of Th cells and a high activity of Tregs and tolerogenic DCs 
(2, 3, 6, 9). Cytokines, growth factors and glycoproteins are also 
involved in peripheral tolerance (32, 33). It has been shown that 
IL-27 subunits and its receptor are upregulated in EAE (34). 
Given that IL-27 is an anti-inflammatory cytokine that induces 
IL-10 production by T cells and suppresses EAE (12, 35, 36), we 
hypothesized that IL-27 plays a role in induction of peripheral 
tolerance. In this study we show that IL-27 is necessary to estab-
lish peripheral tolerance in ongoing autoimmune inflammation. 
Our data also show that tolerance induction is characterized by 
reduced infiltration of cells in the CNS, with greater proportions 
of IL-10+ T cells among infiltrating T cells. Meanwhile, IL-17 and 
GM-CSF, which promote neuroinflammation (23, 37–39), were 
suppressed.
Given that IL-27 signaling in T cell leads to development of 
Tr1 cells through STAT1, AhR, and c-MAF transcription factors 
(13, 14, 16, 40), and that Tr1 cells secrete IL-10 to suppress auto-
immune responses (40, 41), one would expect that peripheral 
tolerance requires IL-27 signaling in T cells. However, unexpect-
edly, we found that lack of IL-27 signaling in T cells did not affect 
induction of peripheral tolerance, as RAG1−/− mice reconstituted 
either with WT or Wsx−/− T cells were similarly susceptible to i.v. 
tolerance induction. Analysis of the T cells showed comparable 
frequencies of Tregs and similar production of inflammatory 
cytokines. This led us to conclude that IL-27 signaling in T cells 
is disposable for tolerance induction during ongoing inflam-
mation. We speculate that IL-27 signaling in T is irrelevant for 
i.v. tolerance induction because effector T cells are resistant to 
the effects of IL-27 (42, 43). In our system, at the time when i.v. 
tolerance is induced, which is after EAE onset, encephalitogenic 
T cell responses have already developed and IL-27 would have no 
effect over these cells. The encephalitogenicity of Wsx−/− CD4+ 
T cells has been previously addressed by our group and others 
(21, 44). It is known that these cells are more pathogenic than 
WT T  cells. However, in this study we found that WT and 
Wsx−/− mice developed a similar EAE course. This discrepancy 
may be due to differences in immunization protocols as in this 
study we used 200 µg of MOG35–55 and 240 ng of Pertussis toxin 
while others used 100  µg of peptide and 200  ng of toxin. We 
speculate that higher doses of MOG35–55 peptide in immuniza-
tion inoculum could promote cell activation-induced death of 
Wsx−/− CD4+ T cells or higher stimulation of Treg cells. Given 
that IL-27 induces tolerogenic DCs that suppress EAE (21), we 
next tested whether IL-27 signaling in DCs plays a role in i.v. 
tolerance induction.
It has been shown that DCs are pivotal for tolerance induction 
via i.v. and mucosal routes (3, 6, 31, 45). We found that in the 
CNS of EAE mice DCs express high levels of IL-27Rα, and that its 
expression is increased in mice subjected to tolerance induction. 
This observation suggests that DCs may be highly susceptible to 
IL-27 signaling or that they can respond to low concentrations 
of IL-27. The presence of DCs that express IL-27Rα rendered 
Wsx−/− mice susceptible to tolerance induction, showing that 
IL-27 signaling in DCs, is necessary for establishment of periph-
eral tolerance to self-Ags during an autoimmune response. 
Further mechanistic analysis showed that disease amelioration 
correlated with a decreased frequency of IL-17- and GM-CSF-
producing cells and a small increase in IL-10-producing T cells 
in the CNS. However, T cells were clearly skewed toward a Th1 
lineage, as their IFN-γ production increased approximately 
threefold compared to PBS-treated mice. It has been shown that 
IFN-γ inhibits IL-17 production and exerts a protective role in 
EAE, and initial reports characterized IL-27 as a Th1-inducing 
cytokine (46, 47). These observations suggest that DC-induced 
T cell-derived IFN-γ may play a role in IL-27-dependent periph-
eral tolerance.
Our results show that IL-27 signaling in DCs contributes 
to peripheral tolerance induction in ongoing EAE and that 
the mechanisms of DC-mediated control of EAE include 
(i) suppression of IL-17 and GM-CSF and (ii) stimulation of Treg 
cells and IFN-γ/IL-10 production by T cells. STATs are a major 
family of kinases that translate cytokine signals to the nucleus 
of the cell and promote transcription of specific genes. STAT1 
and -3 mediate IL-27 signal in T cells, leading to T-bet, c-MAF, 
and AhR expression and IL-10 production (13, 20, 40, 46). In 
the absence of STAT1, IL-27 has an inflammatory effect and 
supports differentiation of naive T cells into Th17 lineage (13). 
STAT1−/− BMDCs remained tolerogenic after IL-27 treatment, 
as EAE severity was reduced in mice recipient of IL-27-treated 
BMDCs. Mascanfroni and colleagues showed previously that 
STAT3 is important for the effects of IL-27 signaling in DCs, 
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as STAT3 is necessary for IL-27-induced expression of CD39, 
an ectonucleotidase (21). Apart from CD39, it has been shown 
that STAT3 also promotes IL-10 production in macrophages and 
Th17  cells (48, 49) and we observed that DCs from i.v. toler-
ized mice were proficient producers of IL-10, not IL-27, in the 
CNS. This led us to hypothesize that IL-27-induced DC-derived 
IL-10 plays a role in tolerance induction. In agreement with 
our hypothesis, lack of IL-10 production by DCs precluded the 
tolerogenic effect of IL-27, even though IL-17 production was 
suppressed. In this system, lack of disease amelioration corre-
lated with reduced numbers of Tregs in i.v. tolerized mice, which 
shows that the mechanism of Treg cell expansion is dependent 
on IL-27-induced DC-derived IL-10.
Distinct subsets of DCs have been identified in mouse 
and human organs, and it is believed that each subset plays a 
specific role in inflammation and tolerance (26, 28, 30, 31, 50). 
In this context, it has been shown that mesenteric lymph node 
resident classical DCs (Lin−CD11c+CD64−MHC-II+, cDCs) are 
important for oral tolerance induction and that absence of MHC 
class II expression in mLN cDCs leads to colitis (51, 52). Using 
CD11b and CD103, we identified three distinct populations of 
classical DCs in the spleen of mice. Previous reports showed that 
CD103+ DCs in the gut are potent inducers of oral tolerance and 
stimulate Treg differentiation through TGF-β and retinoic acid 
(45, 53). Our data show that, on the one hand, CD103+ DCs read-
ily uptake i.v. delivered Ag and that CD11b+CD103+ DCs from 
i.v. tolerized EAE mice were more efficient in inducing IFN-γ 
and IL-10. On the other hand, CD103− and CD11bhiCD103+ 
DCs were more efficient in suppressing IL-17 production by 
naive T cells. Lack of IL-27R in DCs was sufficient to overcome 
this effect. IL-27 production was greater in cultures with CD103− 
DCs from i.v. tolerized mice and this effect was not abrogated 
in the absence of IL-27Rα in DCs. It has been shown that IL-27 
facilitates naive T cell differentiation into Th1 cells even though 
IL-27 does not induce IFN-γ production directly (19). Therefore, 
it would not be surprising if IL-27 acts on both T cells and DCs 
in the establishment of peripheral tolerance. Our data suggest 
that IL-27 skews DCs toward a Th1-inducing profile, which 
leads to suppression of Th17-driven inflammation, such as the 
case of EAE. Our data indicate that CD103− DCs may be an 
initial source of IL-27 following intravenous administration of 
antigen, although more studies are needed to properly address 
this possibility.
Overall, our results indicate that an intricate network among 
DCs subsets results in IL-27-dependent tolerance induction in 
ongoing inflammation. These findings may indicate the need for 
research on the use of IL-27 as an adjunct factor for increasing the 
safety and efficacy of Ag-induced tolerance in harmful immune 
responses in clinical trials.
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FigUre s1 | Oral tolerance induction is IL-27-dependent. WT and Wsx−/− mice 
(n of 5 per group) were immunized with MOG35–55 to induce EAE. At days 14, 16, 
and 18 p.i., mice were fed with 200 µg of MOG35–55 by gavage to induce 
tolerance. (a) Daily clinical scores and cumulative scores of disease severity. 
CNS-infiltrating cells numbers were determined by flow cytometry and 
hemocytometer on day 21 p.i. (B) Flow cytometry analysis of IL-10+, Foxp3+, 
IL-17+, GM-CSF+, and IFN-γ+ CD4+ T cells in the CNS from EAE mice described 
above. (c) Analysis of MHC-II, CD80, and CD86 expression by DCs. Bar graphs 
depict Mean ± SEM. Data are representative or pooled from three independent 
experiments with n of 5 mice per group with similar outcomes. *p < 0.05 
(Two-Way ANOVA with Bonferroni posttest).
FigUre s2 | STAT1-dependent and -independent mechanisms govern 
IL-27-induced tolerogenic DCs. Mature and immature WT and STAT1−/− BMDCs 
were treated with IL-27 (20 ng/mL) for 18 h. (a) Expression of MHC-II, CD80 
and CD86 was determined by flow cytometry. BMDCs were cultivated with WT 
naive CD4+ T cells and anti-CD3 (0.5 µg/mL) for 72 h at 37°C. (B) At the end of 
the culturing period, CD4+ T cells were analyzed by flow cytometry for 
intracellular cytokines. (c) Supernatants were assayed by ELISA. (D) WT and 
STAT1−/− BMDCs (1.5 × 106 cells/mouse) were i.v. transferred to WT recipient 
mice (n = 5/group) three days before immunization for EAE induction. (D) Daily 
clinical scores and cumulative scores of disease severity. CNS-infiltrating cells 
numbers were determined by flow cytometry and hemocytometer on day 21 p.i. 
(e) Flow cytometry analysis of IL-17+, GM-CSF+, IFN-γ+, IL-10+, and Foxp3+ 
CD4+ T cells in the CNS from EAE mice at day 21 p.i. Bar graphs depict 
Mean ± SEM. Data are representative from three independent experiments with 
similar outcomes. *p < 0.05 [One-Way ANOVA in (a,c); Two-Way ANOVA with 
Bonferroni posttest in (D)].
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